Benny Dilmoney

Benny Dilmoney has extensive work experience in the medical industry. Benny is currently the Chief Executive Officer of Magneto Thrombectomy Solutions since August 2019. Additionally, they serve as an Active Board Member at Curesign Ltd. since January 2020. Previously, they held the role of Director of R&D Leveraging & Collaborations at Biosense Webster from December 2014 to 2019. Benny Dilmoney has also served as the CEO of Cardiosonic/Sonivie from November 2009 to April 2015 and also as the CEO of CARDIOGARD from January 2010 to December 2011. Furthermore, they held the position of VP of R&D and Operation, CEO Israeli Site at Neovasc Medical from January 2008 to October 2009. Prior to that, they served as the CEO of Orbix Medical/MIM Medical from an unknown start date to March 2008. Benny Dilmoney's earlier roles include Engineering Manager at Neovasc Medical from an unknown start date to 2006 and Project Manager at Florence Medical from an unknown start date to 2003.

Benny Dilmoney pursued their education at Tel Aviv University, where they obtained a B.Sc. degree in Mechanical Engineering. No specific start or end years were provided for this educational experience.